Inventor · disambiguated record
Christoph Rosenbohm
Also filed as: ROSENBOHM CHRISTOPH
17 granted patents·17 pending applications·624 citations·filing 2003–2020
94Inventor score
Files withROCHE INNOVATION CT COPENHAGEN AS15SANTARIS PHARMA AS8HOFFMANN LA ROCHE3HANSEN HENRIK FRYDENLUND2ROSENBOHM CHRISTOPH2
Top patents by PatentIndex Score
34 records- 0197US9708614B2Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2016·Granted Jul 18, 2017·28 cites·36 claims
- 0297US9428534B2Antisense designSANTARIS PHARMA AS·Filed 2013·Granted Aug 30, 2016·46 cites·78 claims
- 0397US7687617B2Oligonucleotides with alternating segments of locked and non-locked nucleotidesSANTARIS PHARMA AS·Filed 2003·Granted Mar 30, 2010·207 cites·26 claims
- 0496US7569575B2Synthesis of locked nucleic acid derivativesSANTARIS PHARMA AS·Filed 2003·Granted Aug 4, 2009·282 cites·8 claims
- 0592US9994850B2Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Granted Jun 12, 2018·4 cites·19 claims
- 0689US11505569B2GalNAc phosphoramidites, nucleic acid conjugates thereof and their useHOFFMANN LA ROCHE·Filed 2020·Granted Nov 22, 2022·2 cites·2 claims
- 0789US9045518B2Amino-LNA, thio-LNA and alpha-L-oxy-LNCHRISTENSEN SIGNE M·Filed 2003·Granted Jun 2, 2015·19 cites·19 claims
- 0885US8492390B2Synthesis of locked nucleic acid derivativesDETLEF SORENSEN MADS·Filed 2011·Granted Jul 23, 2013·16 cites·8 claims
- 0984US8084458B2Synthesis of locked nucleic acid derivativesSOERENSEN MADS DETLEF·Filed 2009·Granted Dec 27, 2011·15 cites·13 claims
- 1075US8470791B2RNA antagonist compounds for the inhibition of Apo-B100 expressionHANSEN HENRIK FRYDENLUND·Filed 2008·Granted Jun 25, 2013·3 cites·28 claims
- 1173US10577388B2Oligonucleotide conjugation processROCHE INNOVATION CT COPENHAGEN AS·Filed 2016·Granted Mar 3, 2020·1 cites·31 claims
- 1272US2018237777A1Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 1371US9951333B2Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Granted Apr 24, 2018·0 cites·30 claims
- 1471US9890383B2Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Granted Feb 13, 2018·0 cites·30 claims
- 1570US2014128591A1Antisense designSANTARIS PHARMA AS·Filed 2013·Application pending·0 cites
- 1670US2018237778A1Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 1768US2014194614A1Amino-lna, thio-lna and alpha-l-oxy-lnSANTARIS PHARMA AS·Filed 2013·Application pending·0 cites
- 1866US2014128586A1Amino-lna, thio-lna and alpha-l-oxy-lnSANTARIS PHARMA AS·Filed 2013·Application pending·0 cites
- 1966US2016168575A1Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 2065US2016168576A1Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 2163US11591594B2LNA-G processROCHE INNOVATION CT COPENHAGEN AS·Filed 2020·Granted Feb 28, 2023·0 cites·21 claims
- 2263US11555050B2Oligonucleotide conjugation processROCHE INNOVATION CT COPENHAGEN AS·Filed 2020·Granted Jan 17, 2023·0 cites·1 claims
- 2362US8173428B2LNA oligonucleotides and the treatment of cancerROSENBOHM CHRISTOPH·Filed 2008·Granted May 8, 2012·1 cites·2 claims
- 2450US2006154888A1LNA oligonucleotides and the treatment of cancerSANTARIS PHARMA AS·Filed 2005·Application pending·0 cites
- 2549US2018016575A1LNA Gapmer Oligonucleotides Comprising Chiral Phosphorothioate LinkagesROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 2649US2018112217A1Stereospecific Phosphorothioate LNAROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 2746US2020407392A1Lna-dicarboxylic acid derivatives and process for their preparationHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2845US2012322848A1Lna oligonucleotides and the treatment of cancerROSENBOHM CHRISTOPH·Filed 2012·Application pending·0 cites
- 2942US2017327524A1Galnac phosphoramidites, nucleic acid conjugates thereof and their useHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 3042US2010062994A1Adenosine Receptor AntagonistsSANTARIS PHARMA AS·Filed 2007·Application pending·0 cites
- 3141US10815481B2Chiral library screenROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Granted Oct 27, 2020·0 cites·14 claims
- 3241US2019055550A1LNA-G ProcessROCHE INNOVATION CT COPENHAGEN AS·Filed 2016·Application pending·0 cites
- 3337US2009118213A1Rna antagonist compounds for the inhibition of apo-b100 expressionHANSEN HENRIK FRYDENLUND·Filed 2006·Application pending·0 cites
- 3430US2014288299A1ProcessMELDGAARD MICHAEL·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →